Cargando…

Efficacy of a Protein Vaccine and a Conjugate Vaccine Against Co-Colonization with Vaccine-Type and Non-Vaccine Type Pneumococci in Mice

Widespread use of pneumococcal conjugate vaccines (PCVs) has led to substitution of vaccine-type (VT) strains by non-vaccine type (NVT) strains in nasopharyngeal carriage. We compared the efficacy of PCV13 and a nasal protein formulation containing pneumococcal surface protein A (PspA) adjuvanted wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colichio, Gabriela B. C., Oliveira, Giuliana S., Rodrigues, Tasson C., Oliveira, Maria Leonor S., Miyaji, Eliane N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238145/ https://www.ncbi.nlm.nih.gov/pubmed/32290340 http://dx.doi.org/10.3390/pathogens9040278

Ejemplares similares

Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies
por: Oliveira, Giuliana S., et al.
Publicado: (2021)

Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae
por: Tostes, Rafaella O., et al.
Publicado: (2017)

STUDIES ON IMMUNOLOGICAL RELATIONSHIPS AMONG THE PNEUMOCOCCI : IV. ACTIVE IMMUNIZATION OF MICE AGAINST TYPE II PNEUMOCOCCI BY VACCINATION WITH YEAST
por: Sugg, John Y., et al.
Publicado: (1929)

Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci
por: Devine, V. T., et al.
Publicado: (2015)

FACTORS INVOLVED IN THE INFECTION OF MICE AFTER VACCINATION WITH TYPE II PNEUMOCOCCI
por: Neill, James M., et al.
Publicado: (1927)

Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France
por: Janoir, Claire, et al.
Publicado: (2016)

Carriage burden, multiple colonization and antibiotic pressure promote emergence of resistant vaccine escape pneumococci
por: Mitchell, Patrick K., et al.
Publicado: (2015)

Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage
por: Ojal, John, et al.
Publicado: (2017)

Population genetic structure, antibiotic resistance, capsule switching and evolution of invasive pneumococci before conjugate vaccination in Malawi
por: Chaguza, Chrispin, et al.
Publicado: (2017)

Serum levels of anti-PspA and anti-PspC IgG decrease with age and do not correlate with susceptibility to experimental human pneumococcal colonization
por: Araujo, Adriano P., et al.
Publicado: (2021)

Pneumococcal Antibody Concentrations and Carriage of Pneumococci more than 3 Years after Infant Immunization with a Pneumococcal Conjugate Vaccine
por: Akinsola, Adebayo K., et al.
Publicado: (2012)

Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA
por: Metcalf, B.J., et al.
Publicado: (2016)

Decline in Vaccine-Type Streptococcus pneumoniae Serotypes Following Pneumococcal Conjugate Vaccine Introduction in Madagascar
por: Raboba, Julia L, et al.
Publicado: (2021)

Orthogonal modular biosynthesis of nanoscale conjugate vaccines for vaccination against infection
por: Li, Xin, et al.
Publicado: (2021)

Myelin Peptide–Mannan Conjugate Multiple Sclerosis Vaccines: Conjugation Efficacy and Stability of Vaccine Ingredient
por: Matsoukas, John, et al.
Publicado: (2021)

Decrease in Pneumococcal Co-Colonization following Vaccination with the Seven-Valent Pneumococcal Conjugate Vaccine
por: Valente, Carina, et al.
Publicado: (2012)

Conjugate vaccines and the carriage of Haemophilus influenzae type b.
por: Barbour, M L
Publicado: (1996)

651. Non-encapsulation of Pneumococci as a Potential Evasion Mechanism From Vaccines
por: Wajima, Takeaki, et al.
Publicado: (2018)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage
por: Fleming-Dutra, Katherine E., et al.
Publicado: (2014)

Prime-boost-type PspA3 + 2 mucosal vaccine protects cynomolgus macaques from intratracheal challenge with pneumococci
por: Yokota, Chieko, et al.
Publicado: (2023)

Economical Value of Vaccines for the Developing Countries—The Case of Instituto Butantan, a Public Institution in Brazil
por: Ho, Paulo Lee, et al.
Publicado: (2011)

Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland
por: Hjálmarsdóttir, Martha Á., et al.
Publicado: (2020)

Combination of Pneumococcal Surface Protein A (PspA) with Whole Cell Pertussis Vaccine Increases Protection Against Pneumococcal Challenge in Mice
por: Oliveira, Maria Leonor S., et al.
Publicado: (2010)

THE TYPES OF PNEUMOCOCCI IN TUBERCULOUS SPUTUM
por: Lyall, Harold W.
Publicado: (1915)

Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi
por: McCormick, David W., et al.
Publicado: (2011)

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines
por: Lee, Hyunju, et al.
Publicado: (2014)

Serum haptoglobin dynamics in pigs vaccinated or not vaccinated against porcine circovirus type 2
por: Fraile, Lorenzo, et al.
Publicado: (2015)

Impact of Pneumococcal Conjugate Vaccine on Vaccine Serotype–Specific Pneumonia
por: Klugman, Keith P, et al.
Publicado: (2020)

Typing complex meningococcal vaccines to understand diversity and population structure of key vaccine antigens
por: Rodrigues, Charlene M. C., et al.
Publicado: (2019)

On-demand biomanufacturing of protective conjugate vaccines
por: Stark, Jessica C., et al.
Publicado: (2021)

Types of Recombinant Vaccines
por: Giese, Matthias
Publicado: (2015)

Assessing Neutralized Nicotine Distribution Using Mice Vaccinated with the Mucosal Conjugate Nicotine Vaccine
por: Fraleigh, Nya L., et al.
Publicado: (2021)

Carbohydrate Conjugates in Vaccine Developments
por: Lang, Shuyao, et al.
Publicado: (2020)

Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals
por: Nunes, Marta C., et al.
Publicado: (2012)

Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine
por: Akter, Aklima, et al.
Publicado: (2021)

Conjugation, characterization and toxicity of lipophosphoglycan-polyacrylic acid conjugate for vaccination against leishmaniasis
por: Topuzogullari, Murat, et al.
Publicado: (2013)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Invasive Pneumococcal Disease Among Young Children
por: Conklin, Laura, et al.
Publicado: (2014)

Evaluation of digital vaccine card in nursing practice in vaccination room
por: Lopes, Jéssica Pereira, et al.
Publicado: (2019)

Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine
por: Hsiao, Amber, et al.
Publicado: (2022)

Effect of Age and Vaccination With a Pneumococcal Conjugate Vaccine on the Density of Pneumococcal Nasopharyngeal Carriage
por: Roca, A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a6r9qoedjekm9bm0rqu9vof6sc